OpenAlex
PricingAboutJobs
Log inGet started
Work

Growth hormone secretagogue MK-677: No clinical effect on AD progression in a randomized trial

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/01.wnl.0000335163.88054.e7
Authors: J. J. Sevigny, J. M. Ryan, C. H. van Dyck, Y. Peng, C. R. Lines, M. L. Nessly
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Yale University
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: growth hormone secretagogues, Alzheimer's disease, insulin-like growth factor I, disease progression, target engagement, serum IGF-1, cognitive decline, activities of daily living
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1972625995
FWCI: 2.405
Cites: 24
Cited by: 105
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security